What does Fresh Frozen Plasma (FFP) increase in the blood?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

Fresh Frozen Plasma (FFP) increases clotting factors in the blood, specifically replenishing multiple coagulation factors simultaneously, including factors I, II, V, VII, VIII, IX, X, XI, and XIII, as well as proteins C and S 1. When administered, FFP is typically given to patients with coagulopathy due to liver disease, warfarin overdose, massive transfusion, or disseminated intravascular coagulation (DIC). The standard dose is 10-15 mL/kg body weight, which can raise factor levels by approximately 20-30% 2. FFP must be ABO compatible with the recipient and is usually thawed before administration, taking about 30 minutes to prepare. The effects of FFP are temporary, lasting about 6-8 hours for most factors. Potential adverse effects include transfusion reactions, transfusion-associated circulatory overload (TACO), and transfusion-related acute lung injury (TRALI). FFP works by directly replacing the missing or depleted clotting factors, allowing the coagulation cascade to function properly and helping to prevent or control bleeding. Some key points to consider when using FFP include:

  • Emerging evidence supports the early use of FFP to prevent dilutional coagulopathy 2
  • If an experienced clinician anticipates a blood loss of one blood volume, FFP should be infused to prevent coagulopathy
  • While FFP 15 ml.kg–1 is appropriate for uncomplicated cases, increased volumes of FFP will be needed if a consumptive coagulopathy occurs 2

From the Research

FFP Increase in Blood

  • FFP (Fresh Frozen Plasma) is known to increase the levels of various coagulation factors in the blood, including:
    • Vitamin K-dependent clotting factors such as prothrombin, FVII, F IX, and FX 3
    • Fibrinogen levels, which remain stable upon repeated freezing and thawing of FFP 3
  • The increase in these coagulation factors can help to correct coagulopathy in patients with mild abnormalities of coagulation values, although the effectiveness of FFP in this setting is still a topic of debate 4, 5
  • FFP can also increase the levels of other clotting factors, including factor VII, factor IX, and factor X, which are essential for blood coagulation 6
  • The use of FFP to increase coagulation factors in the blood is particularly important in patients with congenital bleeding disorders, such as hemophilia B, and in patients with acquired coagulopathy due to massive bleeding or other causes 6, 7

Related Questions

What are the recommended post‑transfusion monitoring steps and repeat coagulation studies after administering fresh‑frozen plasma (FFP)?
In a hypotensive, tachycardic alcoholic with a bleeding 2‑cm duodenal ulcer, platelet count 53 ×10⁹/L, INR 1.8, normal APTT and fibrinogen, and thromboelastography showing a slightly shortened reaction time with otherwise normal clot kinetics, which is the most appropriate next step: administer factor VIIa, administer prothrombin complex concentrate, consult interventional radiology for embolization, or consult surgery?
What are the implications of a critically elevated partial thromboplastin time (PTT) >139 on Heparin (unfractionated heparin) therapy?
Should fresh frozen plasma be given to a volume‑overloaded patient with rhabdomyolysis‑induced acute kidney injury, direct hyperbilirubinemia and a deranged prothrombin time/international normalized ratio?
What is the recommended algorithm for fresh frozen plasma administration in a patient with decompensated chronic liver disease undergoing major surgery?
What are the recommended cholesterol levels for patients with Diabetes Mellitus (DM)?
What is the duration of treatment with atropine (antimuscarinic agent) and prednisolone (corticosteroid) eye drops for rhegmatogenous retinal detachment?
What are the requirements for Department of Transportation (DOT) certification after a myocardial infarction (MI) and coronary artery bypass grafting (CABG)?
What can be added as a sleep aid to taper a patient off of zopiclone (eszopiclone)?
What two antihypertensive (blood pressure) medications should not be combined?
What is the weight limit for Nexplanon (etonogestrel) implant insertion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.